Analysts at JPMorgan have in a note to clients recapped the Q1 performance of U.S. biotech companies under the firm’s ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE